Publicacións (73) Publicacións de ANGEL SALGADO BARREIRA

filter_list

2025

  1. A comparison of antiplatelet and oral anticoagulation strategies to prevent cerebral microembolism after transcatheter aortic valve implantation: the AUREA trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 21, Núm. 13, pp. e737-e748

  2. ASSOCIATION OF DNA METHYLATION AND ORAL CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Journal of Evidence-Based Dental Practice, Vol. 25, Núm. 4

  3. Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 19, Núm. 9

  4. The utility of brief instruments for depression screening in dialysis patients

    Clinical Kidney Journal, Vol. 18, Núm. 1

2024

  1. Antibiotic Use and Antimicrobial Resistance: A Global Public Health Crisis

    Antibiotics

  2. Clinical usefulness of serum angiotensin converting enzyme in silicosis

    Pulmonology, Vol. 30, Núm. 4, pp. 370-377

  3. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

    Inflammopharmacology, Vol. 32, Núm. 3, pp. 1805-1815

  4. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546

  5. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis

    Diagnostics, Vol. 14, Núm. 14

  6. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study

    International Journal of Neuropsychopharmacology, Vol. 27, Núm. 4

  7. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  8. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology, Vol. 32, Núm. 6, pp. 3697-3705

  9. Validity and Reliability of a Questionnaire on Attitudes, Knowledge, and Perceptions of Pharmacy Students Regarding the Training Received on Antibiotics and Antimicrobial Resistance during Their University Studies

    Antibiotics, Vol. 13, Núm. 9

2023

  1. Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 2

  2. Correlation between the main clinical, imaging, and arthroscopy findings in patients with temporomandibular disorders

    International Journal of Oral and Maxillofacial Surgery, Vol. 52, Núm. 2, pp. 237-244

  3. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  4. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  5. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  6. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  7. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75